Eccrine angiomatous hamartoma treated with multimodal vascular laser and incobotulinum

Yaron Gu; Kelvin Truong; Steven Kossard; Adrian Lim; Deshan F Sebaratnam

doi:10.1002/ski2.434

Eccrine angiomatous hamartoma treated with multimodal vascular laser and incobotulinum

Skin Health Dis. 2024 Aug 13;4(5):e434. doi: 10.1002/ski2.434. eCollection 2024 Oct.

Authors

Yaron Gu^{1

2}, Kelvin Truong^{3

4}, Steven Kossard⁵, Adrian Lim^{4

6}, Deshan F Sebaratnam^{1

2}

Affiliations

¹ Faculty of Medicine and Health University of New South Wales Sydney New South Wales Australia.
² Department of Dermatology Liverpool Hospital Liverpool New South Wales Australia.
³ Department of Dermatology Westmead Hospital Westmead New South Wales Australia.
⁴ Faculty of Medicine and Health The University of Sydney Camperdown New South Wales Australia.
⁵ Kossard Dermatopathologists Laverty Pathology Macquarie Park New South Wales Australia.
⁶ Department of Dermatology Royal North Shore Hospital Sydney New South Wales Australia.

Abstract

Eccrine angiomatous hamartoma (EAH) is a rare benign vascular lesion that is distinguished histologically by vascular and eccrine overgrowth. We report the case of a 46-year-old woman with EAH who was successfully treated with multimodal incobotulinum toxin A, pulsed dye laser and long-pulsed neodymium-doped yttrium aluminium garnet laser.